GoodRx vs Noom
GoodRx costs $50 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between GoodRx and Noom, the first difference is cost: GoodRx is $50 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 6.7.
GoodRx vs Noom price
GoodRx is the cheaper way in: $149 a month against $199 a month at Noom. That is $50 less each month (25% lower), or about $600 over a year of treatment.
Drug by drug: Tirzepatide is cheaper at GoodRx ($299 a month vs $349 a month).
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only Noom lists semaglutide.
On format, GoodRx prices brand-name pens, while Noom prices brand-name pens and compounded injections.
Where each one treats patients
GoodRx lists 50 states, and Noom does not publish where it ships.
Pricing
GoodRx
Noom
What each price covers
Noom's price also covers the clinician visit and coaching, which GoodRx does not claim.
GoodRx does not say what its price includes.
Noom is silent on the medication itself, shipping and lab work.
GoodRx
Inclusions not disclosed.
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, GoodRx scores 6.9 and Noom 6.7 out of 10.
GoodRx is stronger on value (5.0 vs 4.4), accessibility (10.0 vs 5.0) and support (5.0 vs 4.0).
Noom is stronger on user experience (8.0 vs 5.0) and trust & safety (6.5 vs 6.0).
Effectiveness is within half a point.
GoodRx
6.9/10
Noom
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GoodRx nor Noom has an FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Noom |
|---|---|---|
| Starting Price | ✓$149/mo | $199/mo |
| Features | ✓6 features | 2 features |
| States Available | 50 | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Noom
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
GoodRx wins this one, 6.9 to 6.7, above all for oral orforglipron alongside the injectables. It also costs $50 less each month than Noom. Noom fits better if coaching bundled into the price rather than sold separately is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →GoodRx vs Noom: FAQ
Close alternatives to GoodRx and Noom
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.